Completed PHASE4 INTERVENTIONAL 2-arm NCT01553617

VolulyteTM in Cardiac Surgery

Efficacy and Safety of Perioperative Infusion of 6 % Hydroxyethyl Starch 130/0.4 in an Isotonic Electrolyte Solution (VolulyteTM) vs. 5% HSA as Volume Replacement Therapy During Cardiac Surgery for Adult Patients

Sponsor: Fresenius Kabi

Conditions Heart; Dysfunction Postoperative, Cardiac Surgery

Interventions 6% hydroxyethyl starch 130/0.4 in an isotonic electrolyte solution (VolulyteTM) Human serum albumin

Updated 5 times since 2017 Last updated: Jun 25, 2014 Started: Oct 31, 2012 Primary completion: Jan 31, 2014 Completion: Jan 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Heart; Dysfunction Postoperative, Cardiac Surgery, this trial is completed. The trial is conducted by Fresenius Kabi and has accumulated 5 data snapshots since 2012. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Oct 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fresenius Kabi

Data source: Fresenius Kabi

For direct contact, visit the study record on ClinicalTrials.gov .

VolulyteTM in Cardiac Surgery

Status Flow

Change History

Eligibility Summary

Contact Information

Study Locations

Related Trials